RESEARCH-USE BIOSIMILAR ANTIBODY
Ibritumomab
Monoclonal antibody · IgG1
Ibritumomab is a mouse antibody expressed in CHO, targeting CD20/MS4A1. Ibritumomab is equipped with a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 145 kDa. The isotype control for Ibritumomab can refer to Human IgG1 kappa, Isotype Control (HY-P99001).
TARGETMS4A1
YMonoclonal antibody
CATALOGSC-BS-495
CATALOG NUMBERSC-BS-495
MOLECULAR WEIGHTApprox. 144.52 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Ibritumomab is a mouse antibody expressed in CHO, targeting CD20/MS4A1. Ibritumomab is equipped with a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 145 kDa. The isotype control for Ibritumomab can refer to Human IgG1 kappa, Isotype Control (HY-P99001).
Ibritumomab is a recombinant research-use antibody directed against MS4A1.